DORINA TAVERNARO: Open Payments
NPI 1568047371 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 8 payments from 4 companies in 2025. Trend: 2023 $118 · 2024 $299 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| Novo Nordisk Inc | 1 | $29 |
| Intra-Sana Laboratories | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: VRAYLAR, QULIPTA, Wegovy, RELTONE 200 MG, UBRELVY, ZORYVE.
Industry payments across NV — which companies pay providers there.
